Trademark: 79301041
Word
BICYCLE TUMOR-TARGETED IMMUNE CELL AGONIST
Status Date
Tuesday, January 25, 2022
Registration Number
6624273
Registration Date
Tuesday, January 25, 2022
Filing Date
Tuesday, October 27, 2020
Published for Opposition
Tuesday, November 9, 2021
5 Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use and for use as clinical imaging agents
42 Scientific and technological services and research and design relating thereto, namely, scientific research, new product design services, and new study design services in the fields of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; industrial analysis and research services in the fields of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; information, consultancy and advisory services relating to the aforesaid
"TUMOR-TARGETED IMMUNE CELL AGONIST"
Dec 1, 2023
New Representative At Ib Received
Sep 24, 2022
Change Of Name/Address Rec'd From Ib
Aug 1, 2022
Final Decision Transaction Processed By Ib
Jul 2, 2022
Generic Madrid Transaction Sent To Ib
Jul 2, 2022
Generic Madrid Transaction Created
Apr 25, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 25, 2022
Registered-Principal Register
Nov 9, 2021
Official Gazette Publication Confirmation E-Mailed
Nov 9, 2021
Published For Opposition
Oct 20, 2021
Notification Of Notice Of Publication E-Mailed
Oct 5, 2021
Approved For Pub - Principal Register
Sep 22, 2021
Teas/Email Correspondence Entered
Sep 21, 2021
Correspondence Received In Law Office
Sep 21, 2021
Teas Response To Office Action Received
Sep 21, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 21, 2021
Teas Change Of Correspondence Received
Sep 21, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 21, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 21, 2021
Teas Change Of Owner Address Received
Sep 17, 2021
New Representative At Ib Received
Apr 25, 2021
Refusal Processed By Ib
Apr 5, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Apr 5, 2021
Refusal Processed By Mpu
Mar 30, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Mar 29, 2021
Non-Final Action Written
Mar 28, 2021
Assigned To Examiner
Jan 6, 2021
Application Filing Receipt Mailed
Jan 2, 2021
New Application Office Supplied Data Entered
Dec 31, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
